The demand for GLP-1 drugs will grow, and at a potentially substantial rate, if manufacturers obtain FDA-approval for treating nonalcoholic fatty liver disease, polycystic ovary syndrome, sleep apnea, diabetes prevention and other benefits without new serious adverse effects, Patrick Gleason, assistant vice president for Health Outcomes at Prime Therapeutics and Magellan Rx, a pharmacy benefits management company, told BioSpace in an email.
It gently delivers fat reduction without the need to diet or exercise
The true power of Hims & Hers lies in our ability to deliver access to truly bespoke care: from personalized dosing and tailored nutritional guidance to 24/7 access to reach out to their care team, said Craig Primack MD, Head of Weight Loss, Hims & Hers
They are not a shortcut to significant weight loss on their own